HRP20050822B1 - Formulacija za inhalator s odmjerenom dozom koji koristi hidro-fluoro-alkane kao propelente - Google Patents

Formulacija za inhalator s odmjerenom dozom koji koristi hidro-fluoro-alkane kao propelente

Info

Publication number
HRP20050822B1
HRP20050822B1 HRP20050822AA HRP20050822A HRP20050822B1 HR P20050822 B1 HRP20050822 B1 HR P20050822B1 HR P20050822A A HRP20050822A A HR P20050822AA HR P20050822 A HRP20050822 A HR P20050822A HR P20050822 B1 HRP20050822 B1 HR P20050822B1
Authority
HR
Croatia
Prior art keywords
hydro
fluoro
formulation
metered dose
propellants
Prior art date
Application number
HRP20050822AA
Other languages
English (en)
Croatian (hr)
Inventor
George Destefano
Linda Jean Kelash-Cannavo
Original Assignee
Boehringer Ingelheim Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharmaceuticals Inc. filed Critical Boehringer Ingelheim Pharmaceuticals Inc.
Publication of HRP20050822A2 publication Critical patent/HRP20050822A2/xx
Publication of HRP20050822B1 publication Critical patent/HRP20050822B1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
HRP20050822AA 2003-03-20 2004-03-19 Formulacija za inhalator s odmjerenom dozom koji koristi hidro-fluoro-alkane kao propelente HRP20050822B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45611303P 2003-03-20 2003-03-20
PCT/US2004/008375 WO2004084858A2 (en) 2003-03-20 2004-03-19 Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants

Publications (2)

Publication Number Publication Date
HRP20050822A2 HRP20050822A2 (en) 2006-10-31
HRP20050822B1 true HRP20050822B1 (hr) 2013-09-30

Family

ID=33098086

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20050822AA HRP20050822B1 (hr) 2003-03-20 2004-03-19 Formulacija za inhalator s odmjerenom dozom koji koristi hidro-fluoro-alkane kao propelente

Country Status (28)

Country Link
US (1) US7914770B2 (OSRAM)
EP (1) EP1608336B1 (OSRAM)
JP (1) JP4708332B2 (OSRAM)
KR (1) KR101113003B1 (OSRAM)
CN (1) CN1761455A (OSRAM)
AT (1) ATE390125T1 (OSRAM)
AU (1) AU2004224367B2 (OSRAM)
BR (1) BRPI0408547A (OSRAM)
CA (1) CA2519523C (OSRAM)
CO (1) CO5640070A2 (OSRAM)
CY (1) CY1108137T1 (OSRAM)
DE (1) DE602004012718T2 (OSRAM)
DK (1) DK1608336T3 (OSRAM)
EA (1) EA009087B1 (OSRAM)
EC (1) ECSP056029A (OSRAM)
ES (1) ES2304616T3 (OSRAM)
HR (1) HRP20050822B1 (OSRAM)
ME (1) ME00420B (OSRAM)
MX (1) MXPA05009920A (OSRAM)
NO (1) NO336457B1 (OSRAM)
NZ (1) NZ542957A (OSRAM)
PL (1) PL1608336T3 (OSRAM)
PT (1) PT1608336E (OSRAM)
RS (1) RS51663B (OSRAM)
SI (1) SI1608336T1 (OSRAM)
UA (1) UA89751C2 (OSRAM)
WO (1) WO2004084858A2 (OSRAM)
ZA (1) ZA200506463B (OSRAM)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004011381A1 (de) * 2004-03-05 2005-09-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Impaktionsdüse für treibgasbetriebene Dosieraerosole
MXPA06015204A (es) * 2004-07-02 2007-03-15 Boehringer Ingelheim Int Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores.
US20060140873A1 (en) * 2004-12-27 2006-06-29 Chang Heng W Aerosol pharmaceutical compositions
GB0501956D0 (en) * 2005-01-31 2005-03-09 Arrow Internat Nebulizer formulation
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
DE102006053374A1 (de) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmazeutische Formulierung für Aerosole mit zwei oder mehr Wirkstoffen und mindestens einer oberflächenaktiven Substanz
DE102006014433A1 (de) * 2006-03-27 2007-10-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Dosieraerosole für die Verabreichung von pharmazeutischen Zubereitungen
DE102006017320A1 (de) * 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
WO2008047239A2 (en) * 2006-09-21 2008-04-24 Medispray Laboratories Pvt. Ltd. Stable aerosol pharmaceutical formulations
AU2008289109B2 (en) * 2007-08-17 2012-02-02 Centrexion Therapeutics Corporation High concentration local anesthetic formulations
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
US8119694B2 (en) 2008-08-15 2012-02-21 Arcion Therapeutics, Inc. High concentration local anesthetic formulations
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP3508239B1 (de) 2009-05-18 2020-12-23 Boehringer Ingelheim International GmbH Adapter, inhalationseinrichtung und zerstäuber
EA026241B1 (ru) 2009-11-25 2017-03-31 Бёрингер Ингельхайм Интернациональ Гмбх Распылитель
JP5658268B2 (ja) 2009-11-25 2015-01-21 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
JP5874724B2 (ja) 2010-06-24 2016-03-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ネブライザ
US20120204871A1 (en) * 2011-02-10 2012-08-16 Julio Cesar Vega Stable, non-corrosive formulations for pressurized metered dose inhalers
EP2694220B1 (de) 2011-04-01 2020-05-06 Boehringer Ingelheim International GmbH Medizinisches gerät mit behälter
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (de) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Zerstäuber mit kodiermitteln
CN102798044B (zh) * 2012-08-02 2014-09-10 深圳市华星光电技术有限公司 侧入式背光模组
ES2836977T3 (es) 2013-08-09 2021-06-28 Boehringer Ingelheim Int Nebulizador
EP3030298B1 (en) 2013-08-09 2017-10-11 Boehringer Ingelheim International GmbH Nebulizer
ES2874029T3 (es) 2014-05-07 2021-11-04 Boehringer Ingelheim Int Nebulizador
AU2015258107B2 (en) 2014-05-07 2019-12-19 Boehringer Ingelheim International Gmbh Nebulizer
WO2015169732A1 (en) 2014-05-07 2015-11-12 Boehringer Ingelheim International Gmbh Container, nebulizer and use
WO2016164508A1 (en) * 2015-04-10 2016-10-13 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
GB2573297A (en) * 2018-04-30 2019-11-06 Mexichem Fluor Sa De Cv Pharmaceutical composition
US20230271770A1 (en) * 2020-04-21 2023-08-31 Amphastar Pharmaceuticals, Inc. Anti-Viral Pharmaceutical Formulations Administered Via Devices for Lung Targeted Delivery

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045778A (en) * 1992-12-09 2000-04-04 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation
EP1219293A2 (en) * 1997-06-13 2002-07-03 CHIESI FARMACEUTICI S.p.A. Pharmaceutical aerosol compostion

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405598A (en) * 1976-01-30 1983-09-20 Fisons, Limited Composition for treating asthma
GB8824804D0 (en) 1988-10-22 1988-11-30 Fisons Plc Device
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5919435A (en) 1990-11-09 1999-07-06 Glaxo Group Limited Aerosol formulation containing a particulate medicament
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
WO1994025373A1 (en) 1993-04-30 1994-11-10 Minnesota Mining And Manufacturing Company Seal configuration for aerosol canister
JP3172190B2 (ja) 1993-07-15 2001-06-04 ミネソタ マイニング アンド マニュファクチャリング カンパニー 医薬エアロゾルを配給するための器具
PL180880B1 (pl) * 1995-04-14 2001-04-30 Glaxo Wellcome Inc Inhalator z dozymetrem
GB9513084D0 (en) 1995-06-27 1995-08-30 Bespak Plc Dispensing apparatus
SE9701750D0 (sv) 1997-05-12 1997-05-12 Astra Pharma Prod Inhalation device and method of manufacture thereof
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6423298B2 (en) * 1998-06-18 2002-07-23 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceutical formulations for aerosols with two or more active substances
DK1102579T3 (da) * 1998-08-04 2003-07-14 Jago Res Ag Medicinske aerosolformuleringer
IT1303788B1 (it) 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US7074388B2 (en) * 1998-12-10 2006-07-11 Kos Life Science, Inc. Water stabilized medicinal aerosol formulation
US20030008369A1 (en) * 1999-03-03 2003-01-09 Board Of Regents, The University Of Texas System Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
GB0002798D0 (en) 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
EP1241113A1 (en) 2001-03-12 2002-09-18 CHIESI FARMACEUTICI S.p.A. Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
AU2002322314B2 (en) 2001-06-26 2006-08-17 Norton Healthcare, Ltd. An improved aerosol actuator

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6045778A (en) * 1992-12-09 2000-04-04 Boehringer Ingelheim Pharmaceuticals, Inc. Stabilized medicinal aerosol solution formulations
EP1219293A2 (en) * 1997-06-13 2002-07-03 CHIESI FARMACEUTICI S.p.A. Pharmaceutical aerosol compostion
US6261539B1 (en) * 1998-12-10 2001-07-17 Akwete Adjei Medicinal aerosol formulation

Also Published As

Publication number Publication date
EP1608336B1 (en) 2008-03-26
ECSP056029A (es) 2006-01-27
AU2004224367A1 (en) 2004-10-07
CA2519523A1 (en) 2004-10-07
AU2004224367B2 (en) 2009-10-08
EA200501363A1 (ru) 2006-04-28
US7914770B2 (en) 2011-03-29
ZA200506463B (en) 2006-04-26
US20040184994A1 (en) 2004-09-23
WO2004084858A2 (en) 2004-10-07
JP2006520797A (ja) 2006-09-14
WO2004084858A3 (en) 2004-11-04
KR101113003B1 (ko) 2012-02-24
JP4708332B2 (ja) 2011-06-22
EA009087B1 (ru) 2007-10-26
PL1608336T3 (pl) 2008-09-30
NO336457B1 (no) 2015-08-31
CY1108137T1 (el) 2014-02-12
CN1761455A (zh) 2006-04-19
UA89751C2 (ru) 2010-03-10
NO20054839L (no) 2005-10-19
RS51663B (sr) 2011-10-31
KR20050111382A (ko) 2005-11-24
SI1608336T1 (sl) 2008-08-31
CO5640070A2 (es) 2006-05-31
CA2519523C (en) 2012-03-13
HRP20050822A2 (en) 2006-10-31
DE602004012718T2 (de) 2009-05-07
ME00420B (me) 2011-12-20
EP1608336A2 (en) 2005-12-28
MXPA05009920A (es) 2005-11-04
ATE390125T1 (de) 2008-04-15
NZ542957A (en) 2008-09-26
ES2304616T3 (es) 2008-10-16
DK1608336T3 (da) 2008-06-02
DE602004012718D1 (de) 2008-05-08
PT1608336E (pt) 2008-04-21
BRPI0408547A (pt) 2006-03-07
RS20050705A (sr) 2008-04-04

Similar Documents

Publication Publication Date Title
HRP20050822B1 (hr) Formulacija za inhalator s odmjerenom dozom koji koristi hidro-fluoro-alkane kao propelente
AR034298A1 (es) Una valvula dosificadora para un inhalador de dosis dosificada que mejora el flujo de la formulacion a la camara dosificadora
CY1125382T1 (el) Συνθεση για εισπνοη που περιεχει ακλιδινιο για τη θεραπευτικη αντιμετωπιση του ασθματος
UY27740A1 (es) Nuevos compuestos
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
BR0309117A (pt) Kit de inalação compreendendo pó inalável de tiotropium
CU20100123A7 (es) Sales farmacéuticamente aceptables de (3-{[[3-(6-amino-2-butoxi-8-oxo-7,8-dihidro-9h-purin-9-il)propil](3-morfolin-4-ilpropil)amino]metil}fenil)acetato de metilo y sus usos en terapia
IT1317846B1 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
UY31403A1 (es) "derivados novedosos de ({((3-metilfenil)-2h-tetrazol-5-il)-etoxi} -4h-1,2,4-triazol-3-il), composiciones farmacéuticas conteniendolos y uso médico de los mismos".
WO2007137206A3 (en) Unit dose formulations comprising an inhalable solution of albuterol
SE0302546D0 (sv) New compounds
MY163503A (en) Aerosol formulations for the inhalation of beta agonists
YU83301A (sh) Kanister od specijalnog čelika za doziranje aerosola sa pogonskim gasom
ECSP088732A (es) Aerosoles dosificadores para la administración de preparaciones farmacéuticas
BRPI0507225A2 (pt) formulações estáveis de solução farmacêutica para inaladores pressurizados de dose medida
TNSN07289A1 (en) Pharmaceutical aerosol formulations for pressurized metered dose inhalers comprising a sequestering agent
DE60336089D1 (de) Aerosolformulierung umfassend Levalbuterol L-Tartratsalz
DE60312645D1 (de) Darreichungsformen für dns
SV2006002238A (es) Inhibidores de la adenilato ciclasa soluble ref. p-sv-78. 959/gh
BRPI0406814A (pt) Sistema de liberação de produto de tratamento de sensibilidade dentária e métodos de provimento respectivo e de tratamento de dente sensìvel
NO20060743L (no) Nasal farmasoytisk sammensetning av piribedil
UY30234A1 (es) Envase para inhaladores de dosis multiples con propiedades optimizadas de vaciado

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20190305

Year of fee payment: 16

ODRP Renewal fee for the maintenance of a patent

Payment date: 20200306

Year of fee payment: 17

ODRP Renewal fee for the maintenance of a patent

Payment date: 20210316

Year of fee payment: 18

PBON Lapse due to non-payment of renewal fee

Effective date: 20220319